Darunavir chemical structure
Chemical structureResearch use only
CAT. NO. DCAPI1505Featured

Darunavir

Pack Sizes & Prices

TotalUS$300
We match the best price and quality on market.
Product overview

Description & Application

Darunavir(TMC114) is an HIV protease inhibitor.Darunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents.

ParameterValue
Chemical Name(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate
CAS No.206361-99-1
SynonymsTMC114; TMC 114; TMC-114; Darunavir; brand name Prezista.
FormulaC27H37N3O7S
M.Wt547.66
SMILESO=C(O[C@@H]1[C@@]2([H])[C@@](OCC2)([H])OC1)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(S(=O)(C4=CC=C(N)C=C4)=O)CC(C)C
Purity>99%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Darunavir(TMC114) is an HIV protease inhibitor.Darunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheetRequest COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

Doravirine (MK-1439) chemical structureDC9308

Doravirine (MK-1439)

Doravirine is a novel non-nucleoside inhibitor of HIV-1 reverse transcriptase with potent activity against wild-type virus (95% inhibitory concentration 19 nM, 50% human serum).

View activity & prices
TAK-779 chemical structureDC11397

TAK-779

TAK-779 is a potent and selective nonpeptide antagonist of CCR5 and CXCR3, with a Ki of 1.1 nM for CCR5, and effectively and selectively inhibits R5 HIV-1, with EC50 and EC90 of 1.2 nM and 5.7 nM, respectively, in…

View activity & prices
Emtricitabine chemical structureDC5902

Emtricitabine

For the detailed information of Emtricitabine, the solubility of Emtricitabine in water, the solubility of Emtricitabine in DMSO, the solubility of Emtricitabine in PBS buffer, the animal experiment（test） (test) of…

View activity & prices
PD 404182 chemical structureDC12012

PD 404182

PD 404182 is a potent and competitive inhibitor of human dimethylarginine dimethylaminohydrolase 1 (DDAH1), with an IC50 of 9 μM. PD 404182 exhibits antiangiogenic and antiviral activity in vitro[1][2].

View activity & prices
Nevirapine chemical structureDC9019

Nevirapine

Nevirapine is a potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of HIV-1 infection and AIDS.Nevirapine falls in the non-nucleoside reverse…

View activity & prices
GPS491 chemical structureDC47604

GPS491

GPS491 (EC50 = 0.47 μM) suppresses expression of the HIV-1 structural protein Gag and alters HIV-1 RNA accumulation, decreasing the abundance of RNAs encoding the structural proteins while increasing levels of viral…

View activity & prices

Cart

Request quotation